W. Chinratanalab

发表

Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.

M. Pasquini, M. Horowitz, Stephanie J. Lee, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes

A. Kassim, S. Brandt, D. Morgan, 2007, Leukemia & lymphoma.

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

A. Kassim, J. Greer, B. Savani, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: ‘what is the best recipe?’

S. Mineishi, A. Kassim, J. Ferrara, 2005, Bone Marrow Transplantation.

Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.

A. Kassim, S. Brandt, O. Oluwole, 2012, Experimental hematology.

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma

S. Phillips, A. Kassim, R. Cornell, 2018, Bone Marrow Transplantation.

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation.

R. Jayani, A. Kassim, C. Kitko, 2022, Transplantation and cellular therapy.

Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.

M. Torbenson, Linda A. Lee, G. Akpek, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide

Heidi Chen, A. Kassim, M. Jagasia, 2020, EJHaem.

New allergies after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2013, Cytotherapy.

The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia

R. Jayani, A. Kassim, B. Savani, 2020, American journal of hematology.

Allogeneic hematopoietic stem cell transplant (HSCT) in adults with acute myeloid leukemia (AML) – a single program experience

R. Obenchain, A. Kassim, S. Brandt, 2006 .

Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience

G. Mufti, D. Mclornan, A. Kassim, 2019, Front. Oncol..

103: Poor outcome of autologous-bone marrow transplant (auto-BMT) following failed peripheral blood stem cell (PBSC) mobilization

Heidi Chen, A. Kassim, D. Morgan, 2007 .

303: Incidence and outcome of chronic graft-versus-host disease (cGVHD) after allogeneic stem cell transplant (SCT) using National Institute of Health (NIH) consensus criteria

Heidi Chen, A. Kassim, H. Frangoul, 2007 .

Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment

P. McCarthy, B. Bambach, T. Hahn, 2003, Bone Marrow Transplantation.

Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

P. Pohlmann, A. Kassim, J. Greer, 2009, Blood.

Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.

C. Arteaga, F. Yakes, C. Ritter, 2002, Cancer research.

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation

J. Crowe, M. Rock, S. Yoder, 2016, Haematologica.

Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).

Heidi Chen, A. Kassim, J. Greer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2011, Cytotherapy.

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.

Heidi Chen, A. Kassim, J. Greer, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Warner, Heidi Chen, A. Kassim, 2021, Journal of hematology.

Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.

Heidi Chen, A. Kassim, H. Frangoul, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic lymphocytic leukemia/small lymphocytic lymphoma

W. Chinratanalab, S. Sengsayadeth, 2015 .

Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.

A. Kassim, S. Brandt, D. Morgan, 2012, Experimental hematology.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

D. K. Jung, A. Kassim, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma

A. Kassim, C. Mosse, R. Cornell, 2020, Bone Marrow Transplantation.

Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials

Heidi Chen, A. Kassim, J. Greer, 2013, Bone Marrow Transplantation.

Stratification of Allogeneic Hematopoietic Cell Transplant Patients by Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Stephanie J. Lee, A. Artz, A. Loren, 2017 .

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

A. Kassim, J. Greer, B. Savani, 2009 .

B. Savani, W. Chinratanalab, Brent E Salvig, 2019, Clinical hematology international.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

A. Kassim, J. Greer, B. Savani, 2018, Bone Marrow Transplantation.

Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy

Heidi Chen, A. Kassim, C. Mosse, 2018, Bone Marrow Transplantation.

Inhibitors of HER2/neu (erbB-2) signal transduction.

C. Arteaga, W. Chinratanalab, M. B. Carter, 2001, Seminars in oncology.

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

M. Pasquini, M. Horowitz, Stephanie J. Lee, 2016 .

A. Kassim, J. Greer, B. Savani, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.